Related Experiment Video
Updated: Jun 23, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Silica xerogels as pharmaceutical drug carriers
David Quintanar-Guerrero1, Adriana Ganem-Quintanar, María Guadalupe Nava-Arzaluz
1Universidad Nacional Autónoma de México, Facultad de Estudios Superiores Cuautitlán, División de Estudios de Posgrado (Tecnología Farmacéutica), Av. 1 degrees de Mayo s/n, Cuautitlán Izcalli, Estado de México, CP 54740, México.
Abstract:
This review focuses on silica xerogels obtained by the sol-gel method and their application as drug delivery systems. SiO(2) xerogels are potential biomaterials to be used as matrix materials for the extended and controlled release of different kinds of biologically active agents administered by various routes. The article includes some representative examples that describe the encapsulation of bioactive molecules and model compounds inside a silica matrix produced by the conventional sol-gel method or by ultrasound hydrolysis. The drug release rate from xerogels could be modified by adjusting several parameters, such as the type of precursor, the concentration of the catalyst and drying temperature. In vitro and in vivo studies have shown the efficacy and biodegradability of these composites. The potential application of silica xerogels as drug carrier systems is critically analyzed and discussed.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drug Delivery Systems: Different Types
Factors Affecting Dissolution: Particle Size and Effective Surface Area
